Recent studies have shown that NFE2L3 is increased in colorectal cancer and has a positive correlation between NFE2L3 expression in tumor grade and stage (Bury et al., 2019; Chen et al., 2019; Uddin et al., 2019; Liu et al., 2022). This evidence concerns the gene NFE2L3 and neoplasm.